Market Overview

Benzinga's Top #PreMarket Losers

Related OPTT
Stocks Hitting 52-Week Lows
Morning Market Losers
Related HALO
Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo with Modified FOLFIRINOX for Advanced Pancreatic Cancer
Morning Market Movers
Halozyme Shares Plummet as Concerns Halt Trial (Fox Business)

Halozyme Therapeutics (NASDAQ: HALO) fell 23.73% to $8.84 in pre-market trading after the company announced the temporary halt of Phase 2 trial enrollment.

Ocean Power Technologies (NASDAQ: OPTT) dipped 17.89% to $3.12 in the pre-market session after the company announced a proposed public offering of common stock.

CarMax (NYSE: KMX) shares dropped 5.38% to $45.00 in pre-market trading after the company reported downbeat Q4 results and lifted its share-buyback authorization by $1 billion.

Cyclacel Pharmaceuticals (NASDAQ: CYCC) dipped 4.85% to $3.53 in pre-market trading after the company priced an underwritten public offering of 2.857 million shares at $3.50 per share.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (CYCC + HALO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters